Src kinase as a molecular contributor to tau pathology in Alzheimer’s disease
Data support Src as a molecular contributor to Tau pathology in AD, operating at early disease stages, and highlight a potential NEUROD2–Src–Tau axis as a candidate pathway contributing to early pathology.